Recommendations to meet statistical challenges arising from endpoints beyond overall survival in clinical trials on chronic myeloid leukemia

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Practical Statistics for Medical Research.

1992 • 12,008 citations

The Statistical Analysis of Failure Time Data.

1981 • 10,224 citations

Practical Statistics for Medical Research.

1992 • 5,039 citations

A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk

1988 • 4,727 citations

Survival Analysis Techniques for Censored and Truncated Data

1998 • 3,691 citations

Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

2003 • 3,532 citations

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1999 • 2,625 citations

Tutorial in biostatistics: competing risks and multi‐state models

2006 • 2,045 citations

Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia

2010 • 1,604 citations

Survival Analysis

2003 • 1,538 citations

Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

2010 • 1,520 citations

Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial

2010 • 1,484 citations

Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

2009 • 1,306 citations

Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

2006 • 1,296 citations

Modelling Survival Data in Medical Research.

1994 • 1,054 citations

Modelling Survival Data in Medical Research

1994 • 1,036 citations

Analysis of survival by tumor response.

1983 • 1,021 citations

Analysis of survival by tumor response.

1986 • 1,018 citations

The Statistical Analysis of Failure Time Data.

1982 • 927 citations

Survival Analysis Part I: Basic concepts and first analyses

2003 • 826 citations

Competing risk analysis using R: an easy guide for clinicians

2007 • 664 citations

International Randomized Study of Interferon Vs STI571 (IRIS) 8-Year Follow up: Sustained Survival and Low Risk for Progression or Events in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Imatinib.

2009 • 612 citations

Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score

2011 • 473 citations

Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia

2011 • 320 citations

Interferon Alfa Versus Chemotherapy for Chronic Myeloid Leukemia: A Meta-analysis of Seven Randomized Trials

1997 • 282 citations

Issues in Using Progression-Free Survival When Evaluating Oncology Products

2009 • 159 citations

Non‐parametric confidence interval estimation for competing risks analysis: application to contraceptive data

2002 • 106 citations